Xylome is a synthetic biology company focused on manipulating non-conventional yeasts using proprietary genomic tools.
Xylome aims to create ingredients including bio-identical replacements for white RBD palm oil and fish oil, for large markets with sustainability issues. The company uses lipid-based technology in internal and external programs involving hydrophobic drug delivery and topical pharmaceutical products.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Xylome applies lipid-based technology to internal and external programs involving hydrophobic drug delivery and topical pharmaceutical products.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 18, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.